HEADER HYDROLASE 10-JAN-05 2BHG TITLE 3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS COMPND MOL_ID: 1; COMPND 2 MOLECULE: FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.28; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: FOOT-AND-MOUTH DISEASE VIRUS; SOURCE 3 ORGANISM_COMMON: FMDV; SOURCE 4 ORGANISM_TAXID: 12110; SOURCE 5 STRAIN: A10(61); SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PETM-11(3C) KEYWDS FOOT-AND-MOUTH DISEASE VIRUS, PROTEASE, CHYMOTRYPSIN-LIKE KEYWDS 2 CYSTEINE PROTEASE, CAPSID PROTEIN, CORE PROTEIN, COVALENT KEYWDS 3 PROTEIN-RNA LINKAGE, HYDROLASE, LIPOPROTEIN, MYRISTATE, KEYWDS 4 POLYPROTEIN, RNA-DIRECTED RNA POLYMERASE, THIOL PROTEASE, KEYWDS 5 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.R.BIRTLEY,P.BRICK,S.CURRY REVDAT 4 24-FEB-09 2BHG 1 VERSN REVDAT 3 03-APR-07 2BHG 1 REMARK CRYST1 REVDAT 2 21-MAR-05 2BHG 1 REMARK JRNL REVDAT 1 04-FEB-05 2BHG 0 JRNL AUTH J.R.BIRTLEY,S.R.KNOX,A.M.JAULENT,P.BRICK, JRNL AUTH 2 R.J.LEATHERBARROW,S.CURRY JRNL TITL CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS JRNL TITL 2 3C PROTEASE: NEW INSIGHTS INTO CATALYTIC MECHANISM JRNL TITL 3 AND CLEAVAGE SPECIFICITY JRNL REF J.BIOL.CHEM. V. 280 11520 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15654079 JRNL DOI 10.1074/JBC.M413254200 REMARK 2 REMARK 2 RESOLUTION. 1.9 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 4405866.34 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 25721 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1288 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4065 REMARK 3 BIN R VALUE (WORKING SET) : 0.304 REMARK 3 BIN FREE R VALUE : 0.301 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.9 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 209 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2582 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 149 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.0 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.6 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.94 REMARK 3 B22 (A**2) : -5.94 REMARK 3 B33 (A**2) : 11.89 REMARK 3 B12 (A**2) : -1.29 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.25 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.3 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.6 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.78 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38098 REMARK 3 BSOL : 55.6554 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BHG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-JAN-05. REMARK 100 THE PDBE ID CODE IS EBI-22347. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : SI 111 - CHANNEL CUT REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25640 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 26.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA):NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SEE PAPER REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 70.79450 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.87322 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 14.55900 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 70.79450 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 40.87322 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 14.55900 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 70.79450 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 40.87322 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 14.55900 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 81.74645 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 29.11800 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 81.74645 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 29.11800 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 81.74645 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 29.11800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A B, CYS 95 TO LYS REMARK 400 ENGINEERED RESIDUE IN CHAIN A B, CYS 142 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A B, CYS 163 TO ALA REMARK 400 REMARK 400 THIS PROTEIN CONTAINS THREE SUBSTITUTED CYS RESIDUES REMARK 400 (C95K, C142S) TO ENHANCE SOLUBILITY AND ONE (C163A) REMARK 400 WHICH SUBSTITUTES THE ACTIVE SITE NUCLEOPHILE AND REMARK 400 THEREFORE INACTIVATES THE ENZYME. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 SER A 1 REMARK 465 GLY A 2 REMARK 465 ALA A 3 REMARK 465 PRO A 4 REMARK 465 PRO A 5 REMARK 465 THR A 6 REMARK 465 SER A 142 REMARK 465 MSE A 143 REMARK 465 ASP A 144 REMARK 465 GLY A 145 REMARK 465 ASP A 146 REMARK 465 VAL A 206 REMARK 465 GLU A 207 REMARK 465 HIS A 208 REMARK 465 GLY B 0 REMARK 465 SER B 1 REMARK 465 GLY B 2 REMARK 465 ALA B 3 REMARK 465 PRO B 4 REMARK 465 PRO B 5 REMARK 465 THR B 6 REMARK 465 ILE B 74 REMARK 465 LYS B 75 REMARK 465 VAL B 76 REMARK 465 LYS B 77 REMARK 465 GLY B 78 REMARK 465 GLN B 79 REMARK 465 ASP B 80 REMARK 465 MSE B 81 REMARK 465 VAL B 141 REMARK 465 SER B 142 REMARK 465 MSE B 143 REMARK 465 ASP B 144 REMARK 465 GLY B 145 REMARK 465 ASP B 146 REMARK 465 THR B 147 REMARK 465 VAL B 206 REMARK 465 GLU B 207 REMARK 465 HIS B 208 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 7 CG OD1 OD2 REMARK 470 GLN A 9 CD OE1 NE2 REMARK 470 LYS A 10 CG CD CE NZ REMARK 470 LYS A 17 CD CE NZ REMARK 470 LYS A 26 CG CD CE NZ REMARK 470 ILE A 74 CG1 CG2 CD1 REMARK 470 LYS A 75 CG CD CE NZ REMARK 470 LYS A 77 CG CD CE NZ REMARK 470 GLN A 79 CG CD OE1 NE2 REMARK 470 MSE A 81 CG SE CE REMARK 470 ARG A 92 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 ARG A 97 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 101 CG CD CE NZ REMARK 470 ARG A 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 110 CG CD CE NZ REMARK 470 LYS A 170 CE NZ REMARK 470 ASP A 174 CG OD1 OD2 REMARK 470 ARG A 196 CD NE CZ NH1 NH2 REMARK 470 GLN A 200 CG CD OE1 NE2 REMARK 470 LYS A 201 CD CE NZ REMARK 470 ASP B 7 OD1 OD2 REMARK 470 LEU B 23 CG CD1 CD2 REMARK 470 ASP B 24 CG OD1 OD2 REMARK 470 LYS B 26 CG CD CE NZ REMARK 470 GLU B 50 CD OE1 OE2 REMARK 470 LYS B 51 CG CD CE NZ REMARK 470 LYS B 54 CE NZ REMARK 470 ARG B 68 CZ NH1 NH2 REMARK 470 GLU B 73 CG CD OE1 OE2 REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 ARG B 108 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 110 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 31 -169.66 -166.84 REMARK 500 VAL A 140 70.46 58.15 REMARK 500 MSE A 148 64.23 -108.59 REMARK 500 ALA A 156 154.30 179.72 REMARK 500 CYS B 31 -169.86 -167.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 MSE A 81 REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AD BC" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 6-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 7-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 999 REMARK 999 SEQUENCE REMARK 999 CRYSTALLISED SEQUENCE CONTAINS AN ADDITIONAL GLY AT N-TERM REMARK 999 (RESIDUE NUMBER -1). ALSO CONTAINS TRUNCATED C-TERMINUS REMARK 999 (BY 6 RESIDUES). DATABASE ENTRY CONTAINS A PROTEIN REMARK 999 SEQUENCE ERROR. THE SEQUENCE 78-RTGHALRRGTHW-89 IN THE REMARK 999 DATABASE ENTRY SHOULD BE REPLACED BY 78-GQDMLSDAALMV-89. REMARK 999 THIS IS NOT EXPLICITLY CORRECTED IN THE SEQUENCE CONFLICTS REMARK 999 GIVEN BELOW (CONFINED TO ENGINEERED MUTATIONS). REMARK 999 REMARK 999 THE FOLLOWING RESIDUES ARE CONFLICTS BETWEEN THE PROTEIN REMARK 999 AND THE UNIPROT ENTRY, BUT SINCE THEY ARE NOT OBSERVED IN REMARK 999 THE STRUCTURE, THEY CANNOT BE GIVEN SEQADV RECORDS: REMARK 999 B78 (GLY), B79 (GLN), B80 (ASP), B81 (MSE) REMARK 999 RESIDUES A142 (SER) AND B142 (SER) ARE ENGINEERED REMARK 999 MUTATIONS, BUT THEY ARE NOT OBSERVED AND ARE NOT THEREFORE REMARK 999 RECORDED WITH SEQADV RECORDS. DBREF 2BHG A 0 0 PDB 2BHG 2BHG 0 0 DBREF 2BHG A 1 89 UNP P03306 POLG_FMDV1 1650 1738 DBREF 2BHG A 90 207 UNP P03306 POLG_FMDV1 1740 1857 DBREF 2BHG A 208 208 PDB 2BHG 2BHG 208 208 DBREF 2BHG B 0 0 PDB 2BHG 2BHG 0 0 DBREF 2BHG B 1 89 UNP P03306 POLG_FMDV1 1650 1738 DBREF 2BHG B 90 207 UNP P03306 POLG_FMDV1 1740 1857 DBREF 2BHG B 208 208 PDB 2BHG 2BHG 208 208 SEQADV 2BHG LYS A 95 UNP P03306 CYS 95 ENGINEERED MUTATION SEQADV 2BHG ALA A 163 UNP P03306 CYS 163 ENGINEERED MUTATION SEQADV 2BHG LYS B 95 UNP P03306 CYS 95 ENGINEERED MUTATION SEQADV 2BHG ALA B 163 UNP P03306 CYS 163 ENGINEERED MUTATION SEQADV 2BHG GLY A 78 UNP P03306 ARG 1726 CONFLICT SEE REMARK 999 SEQADV 2BHG GLN A 79 UNP P03306 THR 1727 CONFLICT SEE REMARK 999 SEQADV 2BHG ASP A 80 UNP P03306 GLY 1728 CONFLICT SEE REMARK 999 SEQADV 2BHG MSE A 81 UNP P03306 HIS 1729 CONFLICT SEE REMARK 999 SEQADV 2BHG LEU A 82 UNP P03306 ALA 1730 CONFLICT SEE REMARK 999 SEQADV 2BHG SER A 83 UNP P03306 LEU 1731 CONFLICT SEE REMARK 999 SEQADV 2BHG ASP A 84 UNP P03306 ARG 1732 CONFLICT SEE REMARK 999 SEQADV 2BHG ALA A 85 UNP P03306 ARG 1733 CONFLICT SEE REMARK 999 SEQADV 2BHG ALA A 86 UNP P03306 GLY 1734 CONFLICT SEE REMARK 999 SEQADV 2BHG LEU A 87 UNP P03306 THR 1735 CONFLICT SEE REMARK 999 SEQADV 2BHG MSE A 88 UNP P03306 HIS 1736 CONFLICT SEE REMARK 999 SEQADV 2BHG VAL A 89 UNP P03306 TRP 1737 CONFLICT SEE REMARK 999 SEQADV 2BHG LEU B 82 UNP P03306 ALA 1730 CONFLICT SEE REMARK 999 SEQADV 2BHG SER B 83 UNP P03306 LEU 1731 CONFLICT SEE REMARK 999 SEQADV 2BHG ASP B 84 UNP P03306 ARG 1732 CONFLICT SEE REMARK 999 SEQADV 2BHG ALA B 85 UNP P03306 ARG 1733 CONFLICT SEE REMARK 999 SEQADV 2BHG ALA B 86 UNP P03306 GLY 1734 CONFLICT SEE REMARK 999 SEQADV 2BHG LEU B 87 UNP P03306 THR 1735 CONFLICT SEE REMARK 999 SEQADV 2BHG MSE B 88 UNP P03306 HIS 1736 CONFLICT SEE REMARK 999 SEQADV 2BHG VAL B 89 UNP P03306 TRP 1737 CONFLICT SEE REMARK 999 SEQRES 1 A 209 GLY SER GLY ALA PRO PRO THR ASP LEU GLN LYS MSE VAL SEQRES 2 A 209 MSE GLY ASN THR LYS PRO VAL GLU LEU ASN LEU ASP GLY SEQRES 3 A 209 LYS THR VAL ALA ILE CYS CYS ALA THR GLY VAL PHE GLY SEQRES 4 A 209 THR ALA TYR LEU VAL PRO ARG HIS LEU PHE ALA GLU LYS SEQRES 5 A 209 TYR ASP LYS ILE MSE LEU ASP GLY ARG ALA MSE THR ASP SEQRES 6 A 209 SER ASP TYR ARG VAL PHE GLU PHE GLU ILE LYS VAL LYS SEQRES 7 A 209 GLY GLN ASP MSE LEU SER ASP ALA ALA LEU MSE VAL LEU SEQRES 8 A 209 HIS ARG GLY ASN LYS VAL ARG ASP ILE THR LYS HIS PHE SEQRES 9 A 209 ARG ASP THR ALA ARG MSE LYS LYS GLY THR PRO VAL VAL SEQRES 10 A 209 GLY VAL VAL ASN ASN ALA ASP VAL GLY ARG LEU ILE PHE SEQRES 11 A 209 SER GLY GLU ALA LEU THR TYR LYS ASP ILE VAL VAL SER SEQRES 12 A 209 MSE ASP GLY ASP THR MSE PRO GLY LEU PHE ALA TYR LYS SEQRES 13 A 209 ALA ALA THR ARG ALA GLY TYR ALA GLY GLY ALA VAL LEU SEQRES 14 A 209 ALA LYS ASP GLY ALA ASP THR PHE ILE VAL GLY THR HIS SEQRES 15 A 209 SER ALA GLY GLY ASN GLY VAL GLY TYR CYS SER CYS VAL SEQRES 16 A 209 SER ARG SER MSE LEU GLN LYS MSE LYS ALA HIS VAL GLU SEQRES 17 A 209 HIS SEQRES 1 B 209 GLY SER GLY ALA PRO PRO THR ASP LEU GLN LYS MSE VAL SEQRES 2 B 209 MSE GLY ASN THR LYS PRO VAL GLU LEU ASN LEU ASP GLY SEQRES 3 B 209 LYS THR VAL ALA ILE CYS CYS ALA THR GLY VAL PHE GLY SEQRES 4 B 209 THR ALA TYR LEU VAL PRO ARG HIS LEU PHE ALA GLU LYS SEQRES 5 B 209 TYR ASP LYS ILE MSE LEU ASP GLY ARG ALA MSE THR ASP SEQRES 6 B 209 SER ASP TYR ARG VAL PHE GLU PHE GLU ILE LYS VAL LYS SEQRES 7 B 209 GLY GLN ASP MSE LEU SER ASP ALA ALA LEU MSE VAL LEU SEQRES 8 B 209 HIS ARG GLY ASN LYS VAL ARG ASP ILE THR LYS HIS PHE SEQRES 9 B 209 ARG ASP THR ALA ARG MSE LYS LYS GLY THR PRO VAL VAL SEQRES 10 B 209 GLY VAL VAL ASN ASN ALA ASP VAL GLY ARG LEU ILE PHE SEQRES 11 B 209 SER GLY GLU ALA LEU THR TYR LYS ASP ILE VAL VAL SER SEQRES 12 B 209 MSE ASP GLY ASP THR MSE PRO GLY LEU PHE ALA TYR LYS SEQRES 13 B 209 ALA ALA THR ARG ALA GLY TYR ALA GLY GLY ALA VAL LEU SEQRES 14 B 209 ALA LYS ASP GLY ALA ASP THR PHE ILE VAL GLY THR HIS SEQRES 15 B 209 SER ALA GLY GLY ASN GLY VAL GLY TYR CYS SER CYS VAL SEQRES 16 B 209 SER ARG SER MSE LEU GLN LYS MSE LYS ALA HIS VAL GLU SEQRES 17 B 209 HIS MODRES 2BHG MSE A 11 MET SELENOMETHIONINE MODRES 2BHG MSE A 13 MET SELENOMETHIONINE MODRES 2BHG MSE A 56 MET SELENOMETHIONINE MODRES 2BHG MSE A 62 MET SELENOMETHIONINE MODRES 2BHG MSE A 88 MET SELENOMETHIONINE MODRES 2BHG MSE A 109 MET SELENOMETHIONINE MODRES 2BHG MSE A 148 MET SELENOMETHIONINE MODRES 2BHG MSE A 198 MET SELENOMETHIONINE MODRES 2BHG MSE A 202 MET SELENOMETHIONINE MODRES 2BHG MSE B 11 MET SELENOMETHIONINE MODRES 2BHG MSE B 13 MET SELENOMETHIONINE MODRES 2BHG MSE B 56 MET SELENOMETHIONINE MODRES 2BHG MSE B 62 MET SELENOMETHIONINE MODRES 2BHG MSE B 88 MET SELENOMETHIONINE MODRES 2BHG MSE B 109 MET SELENOMETHIONINE MODRES 2BHG MSE B 148 MET SELENOMETHIONINE MODRES 2BHG MSE B 198 MET SELENOMETHIONINE MODRES 2BHG MSE B 202 MET SELENOMETHIONINE HET MSE A 11 8 HET MSE A 13 8 HET MSE A 56 8 HET MSE A 62 8 HET MSE A 81 5 HET MSE A 88 8 HET MSE A 109 8 HET MSE A 148 8 HET MSE A 198 8 HET MSE A 202 8 HET MSE B 11 8 HET MSE B 13 8 HET MSE B 56 8 HET MSE B 62 8 HET MSE B 88 8 HET MSE B 109 8 HET MSE B 148 8 HET MSE B 198 8 HET MSE B 202 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 19(C5 H11 N O2 SE) FORMUL 3 HOH *98(H2 O1) HELIX 1 1 ASP A 7 ASN A 15 1 9 HELIX 2 2 ARG A 45 ALA A 49 1 5 HELIX 3 3 THR A 63 SER A 65 5 3 HELIX 4 4 ILE A 99 HIS A 102 5 4 HELIX 5 5 SER A 195 HIS A 205 1 11 HELIX 6 6 ASP B 7 ASN B 15 1 9 HELIX 7 7 ARG B 45 ALA B 49 1 5 HELIX 8 8 THR B 63 SER B 65 5 3 HELIX 9 9 ILE B 99 PHE B 103 5 5 HELIX 10 10 SER B 195 HIS B 205 1 11 SHEET 1 AA 7 ARG A 60 MSE A 62 0 SHEET 2 AA 7 LYS A 54 LEU A 57 -1 O ILE A 55 N MSE A 62 SHEET 3 AA 7 THR A 16 LEU A 23 -1 O GLU A 20 N MSE A 56 SHEET 4 AA 7 LYS A 26 PHE A 37 -1 O LYS A 26 N LEU A 23 SHEET 5 AA 7 ALA A 40 PRO A 44 -1 O ALA A 40 N VAL A 36 SHEET 6 AA 7 ALA A 85 LEU A 90 -1 O ALA A 86 N VAL A 43 SHEET 7 AA 7 TYR A 67 PHE A 70 -1 O ARG A 68 N VAL A 89 SHEET 1 AB 2 GLU A 73 ILE A 74 0 SHEET 2 AB 2 MSE A 81 LEU A 82 -1 O MSE A 81 N ILE A 74 SHEET 1 AC 2 ARG A 108 MSE A 109 0 SHEET 2 AC 2 LYS A 137 ASP A 138 -1 O LYS A 137 N MSE A 109 SHEET 1 AD 7 PRO A 114 ASN A 121 0 SHEET 2 AD 7 GLY A 125 ALA A 133 -1 O GLY A 125 N ASN A 121 SHEET 3 AD 7 LEU A 151 LYS A 155 -1 O LYS A 155 N GLU A 132 SHEET 4 AD 7 VAL A 188 CYS A 193 -1 O GLY A 189 N TYR A 154 SHEET 5 AD 7 ASP A 174 GLY A 185 -1 O THR A 180 N SER A 192 SHEET 6 AD 7 ALA A 166 ASP A 171 -1 O VAL A 167 N VAL A 178 SHEET 7 AD 7 PRO A 114 ASN A 121 -1 O PRO A 114 N LYS A 170 SHEET 1 BA 7 ARG B 60 MSE B 62 0 SHEET 2 BA 7 LYS B 54 LEU B 57 -1 O ILE B 55 N MSE B 62 SHEET 3 BA 7 THR B 16 LEU B 23 -1 O GLU B 20 N MSE B 56 SHEET 4 BA 7 LYS B 26 PHE B 37 -1 O LYS B 26 N LEU B 23 SHEET 5 BA 7 ALA B 40 PRO B 44 -1 O ALA B 40 N VAL B 36 SHEET 6 BA 7 ALA B 85 LEU B 90 -1 O ALA B 86 N VAL B 43 SHEET 7 BA 7 TYR B 67 PHE B 70 -1 O ARG B 68 N VAL B 89 SHEET 1 BB 2 ARG B 108 MSE B 109 0 SHEET 2 BB 2 LYS B 137 ASP B 138 -1 O LYS B 137 N MSE B 109 SHEET 1 BC 7 PRO B 114 ASN B 121 0 SHEET 2 BC 7 GLY B 125 ALA B 133 -1 O GLY B 125 N ASN B 121 SHEET 3 BC 7 LEU B 151 ALA B 156 -1 O LYS B 155 N GLU B 132 SHEET 4 BC 7 VAL B 188 CYS B 193 -1 O GLY B 189 N TYR B 154 SHEET 5 BC 7 THR B 175 GLY B 185 -1 O THR B 180 N SER B 192 SHEET 6 BC 7 ALA B 166 LYS B 170 -1 O VAL B 167 N VAL B 178 SHEET 7 BC 7 PRO B 114 ASN B 121 -1 O VAL B 116 N LEU B 168 LINK C LYS A 10 N MSE A 11 1555 1555 1.33 LINK C MSE A 11 N VAL A 12 1555 1555 1.33 LINK C VAL A 12 N MSE A 13 1555 1555 1.33 LINK C MSE A 13 N GLY A 14 1555 1555 1.33 LINK C ILE A 55 N MSE A 56 1555 1555 1.33 LINK C MSE A 56 N LEU A 57 1555 1555 1.33 LINK C ALA A 61 N MSE A 62 1555 1555 1.33 LINK C MSE A 62 N THR A 63 1555 1555 1.33 LINK C ASP A 80 N MSE A 81 1555 1555 1.32 LINK C MSE A 81 N LEU A 82 1555 1555 1.33 LINK C LEU A 87 N MSE A 88 1555 1555 1.33 LINK C MSE A 88 N VAL A 89 1555 1555 1.33 LINK C ARG A 108 N MSE A 109 1555 1555 1.33 LINK C MSE A 109 N LYS A 110 1555 1555 1.33 LINK C THR A 147 N MSE A 148 1555 1555 1.33 LINK C MSE A 148 N PRO A 149 1555 1555 1.34 LINK C SER A 197 N MSE A 198 1555 1555 1.33 LINK C MSE A 198 N LEU A 199 1555 1555 1.33 LINK C LYS A 201 N MSE A 202 1555 1555 1.33 LINK C MSE A 202 N LYS A 203 1555 1555 1.33 LINK C LYS B 10 N MSE B 11 1555 1555 1.33 LINK C MSE B 11 N VAL B 12 1555 1555 1.33 LINK C VAL B 12 N MSE B 13 1555 1555 1.33 LINK C MSE B 13 N GLY B 14 1555 1555 1.33 LINK C ILE B 55 N MSE B 56 1555 1555 1.33 LINK C MSE B 56 N LEU B 57 1555 1555 1.33 LINK C ALA B 61 N MSE B 62 1555 1555 1.33 LINK C MSE B 62 N THR B 63 1555 1555 1.33 LINK C LEU B 87 N MSE B 88 1555 1555 1.33 LINK C MSE B 88 N VAL B 89 1555 1555 1.33 LINK C ARG B 108 N MSE B 109 1555 1555 1.33 LINK C MSE B 109 N LYS B 110 1555 1555 1.33 LINK C MSE B 148 N PRO B 149 1555 1555 1.35 LINK C SER B 197 N MSE B 198 1555 1555 1.33 LINK C MSE B 198 N LEU B 199 1555 1555 1.33 LINK C LYS B 201 N MSE B 202 1555 1555 1.33 LINK C MSE B 202 N LYS B 203 1555 1555 1.33 CRYST1 141.589 141.589 43.677 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007063 0.004078 0.000000 0.00000 SCALE2 0.000000 0.008155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022895 0.00000 MTRIX1 1 0.878580 0.456310 -0.140990 0.26814 1 MTRIX2 1 0.457790 -0.888750 -0.023683 4.66770 1 MTRIX3 1 -0.140990 -0.043737 -0.989730 10.78000 1